In vitro and in vivo antifungal effects and mechanism of Daphnetin against Candida albicans
This study demonstrates that Daphnetin (DAP) and its thermo-responsive gel effectively inhibit *Candida albicans* growth and biofilms both in vitro and in vivo by disrupting cell integrity, inducing oxidative stress, and showing low resistance potential, thereby offering a promising multi-target strategy for treating fungal infections.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Fungi are everywhere, living on our skin, in the soil, and even inside our bodies without causing trouble. But when the body's defenses are weakened, some of these microscopic organisms can turn into dangerous invaders. One of the most common culprits is a yeast called Candida albicans. While it often lives harmlessly on the skin or in the mouth, it can cause serious infections if it spreads into the bloodstream or deep into tissues. For decades, doctors have relied on a small handful of drugs to fight these infections. However, just as bacteria have learned to survive antibiotics, these fungi are becoming harder to kill. They develop defenses, hide in protective layers called biofilms, and render standard treatments ineffective. This growing resistance has created a pressing need for new ways to stop these infections, particularly those that can attack the skin and heal wounds.
Researchers at Lanzhou University in China have turned their attention to a natural compound found in plants to see if it offers a new solution. They studied a substance called daphnetin, which is derived from plants in the daphne family. While scientists already knew this compound could fight certain bacteria, its ability to stop Candida albicans was not well understood. The team set out to test whether daphnetin could kill this specific fungus, stop it from forming protective communities, and heal infected wounds in living animals. Their work suggests that this natural molecule attacks the fungus in several different ways at once, making it difficult for the organism to fight back or develop resistance.
The investigation began in the laboratory, where the researchers exposed the fungus to varying amounts of daphnetin to see how much was needed to stop its growth. They found that a very small amount of the substance was enough to halt the fungus, and a slightly higher amount could kill it completely. Unlike many traditional drugs that simply stop the fungus from multiplying, daphnetin acted as a true killer, destroying the cells. To understand how it worked, the scientists looked closely at what happened to the fungal cells after treatment. They discovered that the compound damaged the fungus's outer shell, much like a puncture in a tire causes air to escape. This damage allowed the cell's internal contents, such as proteins and genetic material, to leak out, leading to the cell's death.
Further tests revealed that the substance did not just break the outer wall; it also disrupted the cell's internal environment. It caused a buildup of harmful molecules inside the cell that damaged its structures from the inside out. The researchers also observed that daphnetin prevented the fungus from forming biofilms, which are slimy, protective layers that fungi build to shield themselves from drugs. Even when these protective layers were already formed, the compound was able to break them apart. Perhaps most importantly, the team tested whether the fungus could learn to resist the drug over time. They exposed the fungus to low doses of daphnetin for many generations, a process that usually forces bacteria and fungi to evolve defenses. In this case, the fungus showed no ability to adapt. Even after fifteen generations, the drug remained just as effective as it was on the first day, suggesting that the fungus cannot easily develop a shield against this natural compound.
The study then moved from the test tube to living animals to see if these results held true in a real biological system. The researchers created a model of infected skin wounds on mice, applying the fungus to open sores to mimic a difficult-to-heal infection. They treated these wounds with a gel containing daphnetin, as well as with the drug in a liquid form and a standard antifungal gel for comparison. The results were striking. The wounds treated with the daphnetin gel healed much faster than those left untreated or treated with the liquid drug alone. The gel helped keep the medicine in contact with the wound, allowing it to work more effectively. By the end of the experiment, the mice treated with the daphnetin gel had significantly fewer signs of infection, less swelling, and skin that was regenerating normally. The tissue looked healthy, with new hair follicles forming and inflammation disappearing, whereas the untreated wounds remained red, swollen, and full of the fungus.
These findings point to a promising new approach for treating fungal skin infections. The study demonstrates that daphnetin is not just a weak alternative but a potent agent that attacks the fungus through multiple pathways, leaving it with few ways to survive. Because it damages the cell structure and creates internal chaos simultaneously, the fungus struggles to develop the specific mutations needed to resist it. The success of the gel formulation also highlights the importance of how a medicine is delivered; keeping the drug in place on the skin allowed it to clear the infection and promote healing far better than a simple liquid application. While more research is needed to fully understand the exact molecular targets and to test this in humans, the work provides strong evidence that this natural compound could become a valuable tool in the fight against drug-resistant fungal infections, offering a way to heal wounds that have long been difficult to treat.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.